Morgan Stanley Maintains Equal-Weight on REV Group, Lowers Price Target to $17
Morgan Stanley analyst Courtney Yakavonis maintains REV Group (NYSE:REVG) with a Equal-Weight and lowers the price target from $20 to $17.
54 Biggest Movers From Yesterday
Gainers
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday.
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78.
Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
Midway through trading Wednesday, the Dow traded down 0.45% to 34,942.88 while the NASDAQ fell 1.09% to 15,207.45. The S&P also fell, dropping 0.55% to 4,495.35.
30 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion all-cash deal.
Rev Group Stock Plunges After Mixed Q3 Results, Lowered FY21 Outlook
Rev Group Inc (NYSE: REVG) reported third-quarter sales growth of 1.9% year-over-year to $593.3 million, missing the consensus of $663.4 million.
REV Group Q3 EPS $0.36 Beats $0.34 Estimate, Sales $593.30M Miss $663.40M Estimate
REV Group (NYSE:REVG) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.34 by 5.88 percent. This is a 260 percent increase over earnings of $0.10 per share from the same
Earnings Scheduled For September 8, 2021
Companies Reporting Before The Bell
• Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter.
• Waterdrop (NYSE:WDH) is expected to report earnings for its second quarter.